DNAJB6 and Huntington disease: Investigation of the impact of XP-GFP and XP-GFP-DNAJB6 sEV treatment on the behavioral manifestations of the disease in R6/2 mice is required to assess the therapeutic potential of DNAJB6-loaded exosomes for HD treatment.